[Construction of a highly efficient HBV infection cell model based on HBV co-receptor neuropilin-1]. [PDF]
Zhonghua Gan Zang Bing Za ZhiLiu ZH, He XM, Xu KX, Yu HB, Chen J.
europepmc +1 more source
[Analysis of the prevalence status and clinical characteristics of the hepatitis D virus in the Xinjiang region]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWang ZG +14 more
europepmc +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 2014 摘 要: 【目的】 分析妊娠期慢性乙型肝炎病毒(HBV)携带者病毒载量与妊娠结局的关系? 【方法】 按HBV-DNA是否≥1.0 × 103 U/mL分为:HBV-DNA阳性组,172例;及HBV-DNA阴性组,206例;并设立非HBV携带者作为对照组1144例?分别比较各组产妇的住院时间?分娩孕周?剖宫产率?妊娠期并发症(早产?产后出血?妊娠期糖尿病?妊娠期高血压疾病?胎儿生长受限?羊水量异常?胎儿窘迫) 及新生儿出生体质量?新生儿窒息?新生儿高胆红素血症等的差异?【结果】 HBV-DNA阳性组 ...
doaj
[The partial cure represents an intermediate endpoint on the path to a functional cure, not an ideal endpoint]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhuang H.
europepmc +1 more source
[Clinical research advances for small-molecule nucleic acid drugs in the treatment of chronic hepatitis B]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWang WX +4 more
europepmc +1 more source
丙型肝炎病毒核心抗原在HBV/HCV合并感染者血清中的检测状况及影响因素分析
Zhongshan Daxue xuebao. Yixue kexue ban, 2011 【目的】 探讨丙型肝炎病毒核心抗原(HCVcAg)在乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)合并感染者血清中的检出状况,并分析其影响因素【方法】检测88例慢性丙型肝炎和62例HBV/HCV合并感染患者血清HCVcAg和HCV RNA,对后者血清进行HBV DNAHBeAg检测,分析HCVcAg检出率与HBeAgHBV DNA定量检测关系【结果】 88例慢性丙型肝炎和62例HBV/HCV合并感染者血清HCVcAg的检出率分别是72.7%(64/88)和38.7%(24/62),χ= 17.358,P
doaj
[Research progress in the field of liver failure with artificial livers in 2025]. [PDF]
Zhonghua Gan Zang Bing Za ZhiHan T.
europepmc +1 more source
[Introduction to the update points of the 2025 European Association for the Study of Liver clinical practice guidelines for the management of chronic hepatitis B infection]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhuang H.
europepmc +1 more source
小剂量泼尼松联合恩替卡韦治疗以大量蛋白尿表现的乙肝病毒相关性肾炎3例 附视频
Linchuang shenzangbing zazhi乙肝病毒相关性肾炎（hepatitisBvirus-associated glomerular nephritis,HBV-GN）是指由乙型肝炎病毒（hepatitis B virus,HBV）直接或间接诱发的肾小球肾炎，中国是乙型肝炎的高发国家。据数据统计，中国成年人HBV携带率高达10%以上，其中HBV-GN的发生率约为9.0%[1]。针对HBV-GN目前临床尚无特效疗法，单纯核苷酸类似物治疗大量蛋白尿HBV-GN的尿蛋白缓解率低[2]，临床疗效并不理想。目前通过糖皮质激素 ...
doaj
Zhongshan Daxue xuebao. Yixue kexue ban, 1995 通过检测丙型肝炎抗体与丙型肝炎病毒（ＨＣＶ）核糖核酸的方法对广东地区４４２例慢性乙型肝炎病毒（ＨＢＶ）感染者发生ＨＣＶ重叠感染的状况进行流行病学调查，分析其与输血及血制品的关系。结果显示慢性ＨＢＶ感染患者中ＨＣＶ重叠感染率为９．７３％；其发生主要与治疗性输用血浆有关。与不输血制品相比，输白蛋白、输血浆和输血浆加白蛋白引起ＨＣＶ重叠感染的相对危险度分别为２．１３，１２２．５７和１２５．８４。而且血浆输入量越大，发生重叠感染的危险性也越大。当输注血浆超过１６次，重叠感染率可达７７．７８％
doaj